These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12097800)

  • 1. Matrix metalloproteinases and their inhibitors in exfoliation syndrome.
    Gartaganis SP; Georgakopoulos CD; Mela EK; Exarchou A; Ziouti N; Assouti M; Vynios DH
    Ophthalmic Res; 2002; 34(3):165-71. PubMed ID: 12097800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma.
    Schlötzer-Schrehardt U; Lommatzsch J; Küchle M; Konstas AG; Naumann GO
    Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1117-25. PubMed ID: 12601038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients.
    Jia Y; Hu DN; Sun J; Zhou J
    Curr Eye Res; 2017 Apr; 42(4):600-603. PubMed ID: 28402202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma.
    Määttä M; Tervahartiala T; Harju M; Airaksinen J; Autio-Harmainen H; Sorsa T
    J Glaucoma; 2005 Feb; 14(1):64-9. PubMed ID: 15650607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients.
    Ashworth Briggs EL; Toh T; Eri R; Hewitt AW; Cook AL
    Mol Vis; 2015; 21():1162-72. PubMed ID: 26539028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma.
    Rönkkö S; Rekonen P; Kaarniranta K; Puustjärvi T; Teräsvirta M; Uusitalo H
    Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):697-704. PubMed ID: 17028863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the aqueous humour of patients with primary angle closure glaucoma - a quantitative study.
    Nga AD; Yap SL; Samsudin A; Abdul-Rahman PS; Hashim OH; Mimiwati Z
    BMC Ophthalmol; 2014 Mar; 14():33. PubMed ID: 24655889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
    Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
    J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
    Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels and activation of matrix metalloproteinases in aqueous humor are elevated in uveitis-related secondary glaucoma.
    Määttä M; Tervahartiala T; Vesti E; Airaksinen J; Sorsa T
    J Glaucoma; 2006 Jun; 15(3):229-37. PubMed ID: 16778646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis.
    Montagnana M; Volpe A; Lippi G; Caramaschi P; Salvagno GL; Biasi D; Bambara LM; Guidi GC
    Clin Biochem; 2007 Aug; 40(12):837-42. PubMed ID: 17493602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta1, matrix-metalloproteinase-2 and its tissue inhibitor in patients with pseudoexfoliation glaucoma/syndrome.
    Djordjević-Jocić J; Zlatanović G; Veselinović D; Jovanović P; Djordjević V; Zvezdanović L; Stanković-Babić G; Vujanović M; Cekić S; Zenkel M; Schlotzer-Schrehardt U
    Vojnosanit Pregl; 2012 Mar; 69(3):231-6. PubMed ID: 22624408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
    Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of matrix metalloproteinases and their tissue inhibitors as possible contributors to corneal droplet formation in climatic droplet keratopathy.
    Holopainen JM; Serra HM; Sánchez MC; Sorsa T; Zalentein WN; Barcelona PF; Moilanen JA; Tervahartiala T; Tervo TM; Cafaro TA; Virtanen I; Urrets-Zavalia EA; Bhattacharya SK; Urrets-Zavalia JA
    Acta Ophthalmol; 2011 Sep; 89(6):569-74. PubMed ID: 19900203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.
    Adithi M; Nalini V; Kandalam M; Krishnakumar S
    J Pediatr Hematol Oncol; 2007 Jun; 29(6):399-405. PubMed ID: 17551402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
    Papakonstantinou E; Dionyssopoulos A; Aletras AJ; Pesintzaki C; Minas A; Karakiulakis G
    J Am Acad Dermatol; 2004 Oct; 51(4):526-33. PubMed ID: 15389186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
    Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered matrix metalloproteinases and tissue inhibitors of metalloproteinases in embryos from diabetic rats during early organogenesis.
    Higa R; Kurtz M; Capobianco E; Martínez N; White V; Jawerbaum A
    Reprod Toxicol; 2011 Dec; 32(4):449-62. PubMed ID: 21963884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome.
    Ho SL; Dogar GF; Wang J; Crean J; Wu QD; Oliver N; Weitz S; Murray A; Cleary PE; O'Brien C
    Br J Ophthalmol; 2005 Feb; 89(2):169-73. PubMed ID: 15665347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.